President Trump announces significant tariffs on pharmaceutical imports to revive U.S. manufacturing. Will this bold move shake the global drug market and impact upcoming midterms?
As President Trump prepares to unveil a major tariff plan, pharmaceutical companies are lobbying for a gradual implementation to mitigate the impact on drug prices and supply. With potential tariffs looming, how will the industry adapt?
